ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2534

Frequency of Ocular and Gastrointestinal Lesions Is Increased in Japanese Behçet’s Disease Patients with HLA-B61

Koichi Sugihara1, Risa Wakiya2, Hiromi Shimada1, Taichi Miyagi3, Yusuke Ushio3, Mao Mizusaki1, Kanako Chujo3, Naoto Manabe3, Mayuko Wada1, Shusaku Nakashima1 and Hiroaki Dobashi1, 1Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki-cho, Kita-gun, Kagawa, Japan, 2Division of Rheumatology, Department of Internal Medicine, Toho University, Ota City Tokyo, Japan, 3Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Miki-cho, Kita-gun, Japan

Meeting: ACR Convergence 2025

Keywords: Behçet's Syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2524–2546) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The associations of HLA-B51 and HLA-A26 with the onset of Behçet’s disease (BD) are well established. Although BD manifests with a variety of clinical lesions, the relationships between specific HLA types and individual disease manifestations—especially HLA types beyond B51 and A26—remain unclear.This study aimed to investigate the associations between HLA-A and HLA-B alleles and clinical lesions in Japanese patients with BD.

Methods: This retrospective study included patients with BD who visited Kagawa University Hospital in 2024 and whose HLA-A and HLA-B types had been analyzed. All patients were ≥18 years and met the International Criteria for Behçet’s Disease. The frequency of HLA-A and HLA-B alleles in BD patients was compared with that in healthy Japanese individuals. Additionally, the prevalence of specific BD manifestations was analyzed according to HLA alleles. Statistical analyses were performed using the Mann–Whitney U test and Fisher’s exact test.

Results: A total of 36 patients were included (mean age 44.3 years; 75.0% female; mean disease duration 8.6 years). As previously reported, HLA-B51 and HLA-A26 were significantly more prevalent in BD patients than in healthy controls (36.1% vs. 17.6%, p = 0.0074; 44.4% vs. 20.7%, p = 0.0014, respectively). No significant differences were found for other HLA alleles.Among BD patients, those with HLA-B61 had significantly higher frequencies of ocular and gastrointestinal involvement compared to those without HLA-B61 (61.5% vs. 21.7%, p = 0.0298; 30.8% vs. 4.4%, p = 0.0470, respectively). No significant differences in age, sex, or disease duration were observed between HLA-B61–positive and –negative groups. Additionally, patients with HLA-A2 were significantly less likely to present with arthritis (p = 0.0144).

Conclusion: While HLA-B61 has been previously linked to ankylosing spondylitis and Crohn’s disease, this study suggests a novel association between HLA-B61 and ocular and gastrointestinal manifestations in Japanese patients with Behçet’s disease. Further studies with larger cohorts are warranted to confirm these findings.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: K. Sugihara: None; R. Wakiya: None; H. Shimada: None; T. Miyagi: None; Y. Ushio: None; M. Mizusaki: None; K. Chujo: None; N. Manabe: None; M. Wada: None; S. Nakashima: None; H. Dobashi: None.

To cite this abstract in AMA style:

Sugihara K, Wakiya R, Shimada H, Miyagi T, Ushio Y, Mizusaki M, Chujo K, Manabe N, Wada M, Nakashima S, Dobashi H. Frequency of Ocular and Gastrointestinal Lesions Is Increased in Japanese Behçet’s Disease Patients with HLA-B61 [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/frequency-of-ocular-and-gastrointestinal-lesions-is-increased-in-japanese-behcets-disease-patients-with-hla-b61/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frequency-of-ocular-and-gastrointestinal-lesions-is-increased-in-japanese-behcets-disease-patients-with-hla-b61/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology